Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Clin Pharmacol Ther. 2015 Mar 15;97(4):419–427. doi: 10.1002/cpt.66

Figure 1.

Figure 1

Morphine (circles, A), morphine-3-glucuronide (triangles, B), and morphine-6-glucuronide (squares, B) serum concentration vs. time profiles in healthy subjects (grey) and patients with NASH (black). Data are presented as geometric mean and 95% confidence intervals.